Search

everythinglearnresearchcommunity

for

Search:↓

Sertoli-Leydig cell tumors are rare ovarian tumors that can cause symptoms like menorrhagia.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Women with both type 2 diabetes and PCOS have worse metabolic issues but milder reproductive symptoms after sleeve gastrectomy.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

Understanding genes and hormones is crucial for managing male puberty and sex development disorders.

Using a protocol with LH improves pregnancy rates in patients with low ovarian reserve.

Hair transplant works well, but needs more research for better results.

Early diagnosis and personalized treatment improve fertility and quality of life for women with reproductive endocrine disorders.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Improved access to hair removal is crucial for transgender individuals before feminizing surgeries.

Finasteride caused breast enlargement in two men, which improved after stopping the medication.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

Individuals with male pseudohermaphroditism often do better raised as females with early surgery.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

Estrogens can slow skin aging after menopause, but can't restore youthful skin.

Flutamide may slightly improve hair loss in women, but finasteride does not work.